Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV prevention in developed countries

T J Coates1, P Aggleton, F Gutzwiller

  • 1Department of Medicine, University of California, San Francisco 94105, USA.

Lancet (London, England)
|October 26, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel.

AIDS and behavior·2022
Same author

Preventing Injection Drug use Initiation: State of the Evidence and Opportunities for the Future.

Journal of urban health : bulletin of the New York Academy of Medicine·2017
Same author

Archives of gynecology and obstetrics·2016
Same author

Missed epidemics and missing links: international birth cohort trends in multiple sclerosis.

European journal of neurology·2012
Same author

Firearm suicides and availability of firearms: the Swiss experience.

European psychiatry : the journal of the Association of European Psychiatrists·2010
Same author

Culture, risk factors and mortality: can Switzerland add missing pieces to the European puzzle?

Journal of epidemiology and community health·2009
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

HIV prevention in developed nations has seen successes like behavioral changes and safer blood supplies, but failures highlight the need for new strategies to reach at-risk groups and overcome political hurdles.

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Disease Control

Background:

  • Developed countries have achieved significant successes in Human Immunodeficiency Virus (HIV) prevention.
  • Notable successes include behavioral shifts in key populations, prevention of vertical transmission through antiviral therapy, and enhanced blood supply safety.
  • However, persistent challenges and failures indicate areas requiring further intervention and strategic development.

Purpose of the Study:

  • To analyze the successes and failures of HIV prevention strategies in developed countries.
  • To identify key obstacles hindering comprehensive HIV prevention.
  • To outline the necessity for novel approaches to address remaining prevention gaps.

Main Methods:

  • Review and synthesis of existing data on HIV prevention outcomes in developed nations.

Related Experiment Videos

  • Analysis of behavioral trends, transmission routes, and public health interventions.
  • Identification of barriers to effective HIV prevention implementation.

    • Main Results:

    • Documented successes in specific demographic groups and interventions.
    • Highlighted failures in reaching certain populations and overcoming systemic obstacles.
    • Identified critical needs for targeted strategies for individuals with ongoing risk behaviors, young people initiating sexual activity or drug use, and overcoming political opposition.

    Conclusions:

    • While progress in HIV prevention is evident, significant challenges remain.
    • New, targeted strategies are essential to address persistent high-risk behaviors and reach vulnerable populations.
    • Overcoming political and social barriers is crucial for the future success of HIV prevention efforts.